![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS11155 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-RAR alpha |
克隆性 | |
靶點(diǎn) | 詳見說(shuō)明書 |
適應(yīng)物種 | 詳見說(shuō)明書 |
形態(tài) | 詳見說(shuō)明書 |
宿主 | 詳見說(shuō)明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見說(shuō)明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human Retinoic acid Receptor Alpha |
中文名稱 維甲酸受體RAR α/RAR α抗體品牌
英文名稱 Anti-RAR alpha
別 名 Acute Promelocytic Leukemia Breakpoint Cluster Region; Acute Promelocytic Leukemia Breakpoint Cluster Region; NR1B1; Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein; Nuclear receptor subfamily 1 group B member 1; Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form; RAR A; RAR alpha; RAR alpha; RAR alpha form; RAR alpha form; RAR; RAR-alpha; RARA; RARA; RARA protein; RARA/PML Fusion Gene; RARA/PML Fusion Gene; RARA_HUMAN; RARalpha; RARalpha1; Retinoic acid receptor alpha; Retinoic acid receptor alpha polypeptide
產(chǎn)品屬性:
維甲酸受體RAR α/RAR α抗體品牌 濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 48kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Retinoic acid Receptor Alpha
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
維甲酸受體RAR α/RAR α抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Retinoic acid receptor alpha (RAR-alpha) is a receptor for retinoic acid. This metabolite has profound effects on vertebrate development. Retinoic acid is a morphogen and is a powerful teratogen. This receptor controls cell function by directly regulating gene expression. Subunit: Interacts with CDK7 (By similarity). Interacts with NCOA3 and NCOA6 coactivators, leading to a strong increase of transcription of target genes.
Function : Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. RARA plays an essential role in the regulation of retinoic acid-induced germ cell development during spermatogenesis. Has a role in the survival of early spermatocytes at the beginning prophase of meiosis. In Sertoli cells, may promote the survival and development of early meiotic prophase spermatocytes. In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). Regulates expression of target genes in a ligand-dependent manner by recruiting chromatin complexes containing MLL5. Mediates retinoic acid-induced granulopoiesis.
Subunit : Heterodimer; with RXRA. Binds DNA preferentially as a heterodimer. Interacts with CDK7 By similarity. Interacts with coactivators NCOA3 and NCOA6. Interacts with NCOA7; the interaction requires ligand-binding. Interacts with MLL5. Interacts (via the ligand-binding domain) with PRAME; the interaction is ligand (retinoic acid)-dependent. Interacts with AKT1; the interaction phosphorylates RARA and represses transactivation. Interacts with PRKAR1A; the interaction negatively regulates RARA transcriptional activity. Interacts with NCOR1 and NCOR2. Interacts with PRMT2. Interacts with LRIF1. Interacts with ASXL1 and NCOA1.
Subcellular Location : Nucleus. Cytoplasm. Nuclear localization depends on ligand binding, phosphorylation and sumoylation. Transloaction to the nucleus in the absence of ligand is dependent on activation of PKC and the downstream MAPK phosphorylation.
Post-translational modifications : Phosphorylated on serine and threonine residues. Phosphorylation does not change during cell cycle. Phosphorylation on Ser-77 is crucial for transcriptional activity. Phosphorylation by AKT1 is required for the repressor activity but has no effect on DNA binding, protein stability nor subcellular localization. Phosphorylated by PKA in vitro. This phosphorylation on Ser-219 and Ser-369 is critical for ligand binding, nuclear localization and transcriptional activity in response to FSH signaling.
Sumoylated with SUMO2, mainly on Lys-399 which is also required for SENP6 binding. On all-trans retinoic acid (ATRA) binding, a confromational change may occur that allows sumoylation on two additional site, Lys-166 and Lys-171. Probably desumoylated by SENP6. Sumoylation levels determine nuclear localization and regulate ATRA-mediated transcriptional activity.
Trimethylation enhances heterodimerization with RXRA and positively modulates the transcriptional activation.
Ubiquitinated.
DISEASE : Chromosomal aberrations involving RARA are commonly found in acute promyelocytic leukemia. Translocation t(11;17)(q32;q21) with ZBTB16/PLZF; translocation t(15;17)(q21;q21) with PML; translocation t(5;17)(q32;q11) with NPM. The PML-RARA oncoprotein requires both the PML ring structure and coiled-coil domain for both interaction with UBE2I, nuclear microspeckle location and sumoylation. In addition, the coiled-coil domain functions in blocking RA-mediated transactivation and cell differentiation.
Similarity : Belongs to the nuclear hormone receptor family. NR1 subfamily.
Contains 1 nuclear receptor DNA-binding domain.
Database links : Entrez Gene: 5914 Human
Entrez Gene: 19401 Mouse
Entrez Gene: 24705 Rat
Omim: 180240 Human
SwissProt: P10276 Human
SwissProt: P11416 Mouse
Unigene: 654583 Human
Unigene: 439744 Mouse
類固醇受體(Steroid Receptors) RAR-α在人組織細(xì)胞分化過(guò)程中具有重要作用,尤其在分化的特殊階段起到一定的作用,在造血細(xì)胞中,RARα表達(dá)豐富。
實(shí)驗(yàn)流程:
全、新、優(yōu)、品、好四大特點(diǎn):
維甲酸受體RAR α/RAR α抗體品牌 全:公司提供上萬(wàn)種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★維甲酸受體RAR α/RAR α抗體品牌 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品:
IL-14/Taxilin alpha 白介素14抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-Ack1 醋酸激酶1抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-CDKN1A/P21 (Thr57) 磷酸化p21蛋白抗體 規(guī)格 0.1ml
雞IgG 干粉 10mg/50mg 國(guó)產(chǎn)
Wilms Tumor Protein 英文名稱: 腎母細(xì)胞瘤蛋白抗體 0.1ml
DPP2 英文名稱: 溶酶體絲酸蛋白酶DPP2抗體 0.1ml
Anti-Ack1 醋酸激酶1抗體Multi-class antibodies規(guī)格: 0.2ml
Anti-PACAP-38 /FITC 熒光素標(biāo)記腺苷酸環(huán)化酶激活肽-38抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rabbit Anti-rat IgG/Biotin 生物素化兔抗大鼠IgGMulti-class antibodies規(guī)格: 0.1ml
周期素B1抗體 Anti-Cyclin B1 0.1ml
Rabbit anti-MG IgG/PE-Cy5.5 PE-Cy5.5標(biāo)記的兔抗長(zhǎng)爪沙鼠IgG 0.1ml
FLCN 英文名稱: 卵巢濾泡激素抗體(BHD綜合征) 0.1ml
Rhesus antibody Rh phospho-VEGF receptor 2 (Tyr1059) 磷酸化內(nèi)皮生長(zhǎng)因子受體2抗體 規(guī)格 0.1ml
Rabbit Anti-rat IgG/Biotin 生物素化兔抗大鼠IgGMulti-class antibodies規(guī)格: 0.1ml
Streptococcus suis 2 英文名稱: 2型豬鏈球菌菌體蛋白抗體 0.2ml
Eph receptor A5 英文名稱: 酪酸蛋白激酶A5受體抗體 0.1ml
抗磷酸化原癌基因c-kit抗體 Anti-phospho-c-kit/SCFR/CD117 0.1ml
Anti-VCP/p97 /FITC 熒光素標(biāo)記抗含纈酪肽蛋白抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh phospho-HDAC6 (Ser22) 磷酸化組蛋白去乙?;?抗體 規(guī)格 0.1ml
CD44 CD44抗原 (多肽抗原)Multi-class antibodies規(guī)格: 0.5mg
人平滑肌細(xì)胞
Panc10.05 *腺癌
LTF Others Human 人 LTF / Lactoferrin / Lactoansferrin 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0450SW 982(人滑膜細(xì)胞)5×106cells/瓶×2
人腎近曲小管上皮細(xì)胞RNAHRPTEpiC miRNA5 μg
人二倍體細(xì)胞;HEL 人小腸平滑肌細(xì)胞完全培養(yǎng)基 100mL
CL-0199RSC96(大鼠雪旺細(xì)胞)5×106cells/瓶×2
ALPI Others Human 人 Alkaline Phosphatase / ALPI 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
小鼠食管平滑肌細(xì)胞完全培養(yǎng)基 100mL
MDCK[NBL-2]狗腎上皮細(xì)胞 MDCK[NBL-2] canine kidney epithelial cells MEM+10% FBS
白細(xì)胞介素-6超家族
R 1610(倉(cāng)鼠肺細(xì)胞) 5×106cells/瓶×2 HL-60(原髓細(xì)胞)
維甲酸受體RAR α/RAR α抗體品牌 人平滑肌細(xì)胞
Panc10.05 *腺癌
LTF Others Human 人 LTF / Lactoferrin / Lactoansferrin 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0450SW 982(人滑膜細(xì)胞)5×106cells/瓶×2
人腎近曲小管上皮細(xì)胞RNAHRPTEpiC miRNA5 μg
人二倍體細(xì)胞;HEL 人小腸平滑肌細(xì)胞完全培養(yǎng)基 100mL